Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Circulating neurofilament… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction

Artikel i vetenskaplig tidskrift
Författare Annie Pedersen
Tara M Stanne
Staffan Nilsson
Sofia Klasson
Lars Rosengren
Lukas Holmegaard
Katarina Jood
Kaj Blennow
Henrik Zetterberg
Christina Jern
Publicerad i Journal of Neurology
Volym 266
Nummer/häfte 11
Sidor 2796-2806
ISSN 0340-5354
Publiceringsår 2019
Publicerad vid Institutionen för matematiska vetenskaper
Institutionen för biomedicin
Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi
Institutionen för neurovetenskap och fysiologi, sektionen för klinisk neurovetenskap
Institutionen för medicin
Sidor 2796-2806
Språk en
Länkar dx.doi.org/10.1007/s00415-019-09477...
Ämnesord Biomarkers, Cerebrovascular disease, Prognosis, Stroke in young adults, wallerian degeneration, cerebrospinal-fluid, biomarker, chain, classification, history, Neurosciences & Neurology
Ämneskategorier Neurologi, Neurovetenskaper

Sammanfattning

Background and purpose Neurofilament light chain (NfL) is a marker of neuroaxonal damage. We aimed to study associations between serum NfL (sNfL) concentrations at different time points after ischemic stroke and outcomes. Methods We prospectively included ischemic stroke cases (n = 595, mean age 59 years, 64% males) and assessed outcomes by both the modified Rankin Scale (mRS) and the NIH stroke scale (NIHSS) at 3 months and by mRS at 2 years. In a subsample, long-term (7-year) outcomes were also assessed by both mRS and NIHSS. We used the ultrasensitive single-molecule array assay to measure sNfL in the acute phase (range 1–14, median 4 days), after 3 months and 7 years in cases and once in controls (n = 595). Results Acute-phase sNfL increased by the time to blood-draw and highest concentrations were observed at 3 months post-stroke. High sNfL associated to stroke severity and poor outcomes, and both associations were strongest for 3-month sNfL. After adjusting for age, previous stroke, stroke severity, and day of blood draw, 3-month sNfL was significantly associated to both outcomes at all time points (p < 0.01 throughout). For all main etiological subtypes, both acute phase and 3-month sNfL were significantly higher than in controls, but the dynamics of sNfL differed by stroke subtype. Conclusions The results from this study inform on sNfL in ischemic stroke and subtypes over time, and show that sNfL predicts short- and long-term neurological and functional outcomes. Our findings suggest a potential utility of sNfL in ischemic stroke outcome prediction.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?